Friday, November 22, 2024
HomeTagsClinical-stage

clinical-stage

Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple Myeloma

Data Describing Activity of P-BCMA-ALLO1 in BCMA-Experienced Patients to be Presented at Upcoming AACR Meeting Poseida Therapeutics, Inc., a clinical-stage cell and gene therapy company...

Nectero Medical Receives FDA Fast Track Designation for Nectero EAST® System

Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, announced that the U.S. Food and Drug Administration (FDA) has granted...

AI Therapeutics Announces Investigator Initiated Phase 2 Trial at UCSF to Study LAM-001 in Patients With Bronchiolitis Obliterans Syndrome (BOS) Post-Lung Transplant

AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the commencement of an investigator initiated Phase 2 study...

Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0803 for the Treatment of Amyotrophic Lateral Sclerosis

Cellenkos, Inc., a clinical stage biotech company that focuses on developing transformative cellular therapeutics for treatment of inflammatory disorders and autoimmune diseases, today announced...

Moleculin Announces Completion of Second Single Ascending Dose Cohort in Phase 1a Clinical Trial

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary results...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics